PCM
GILD icon

Polymer Capital Management’s Gilead Sciences GILD Stock Holding History

Polymer Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Sell
2,655
-7
-0.3% -$922 0.04% 492
2026
Q1 		$371K Buy
2,662
+759
+40% +$106K 0.04% 524
2025
Q4 		$234K Sell
1,903
-1,822
-49% -$221K 0.02% 683
2025
Q3 		$413K Buy
+3,725
New +$423K 0.04% 462
2025
Q2 		– Sell
-4,650
Closed -$521K – 670
2025
Q1 		$521K Buy
+4,650
New +$480K 0.13% 158

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Polymer Capital Management's GILD Position: Q2 2026 in Review

Polymer Capital Management reduced its Gilead Sciences (GILD) stake by 0.26% in Q2 2026, selling an estimated $922 and leaving 2,655 shares worth $335K. The position accounts for 0.04% of the portfolio, ranked #492.

Polymer Capital Management first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. The position peaked at $521K in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Polymer Capital Management held 2,655 shares of Gilead Sciences worth $335K as of Q2 2026.
  • Polymer Capital Management sold 7 Gilead Sciences shares in Q2 2026, an estimated $922.
  • Gilead Sciences made up 0.04% of Polymer Capital Management's portfolio in Q2 2026, its #492 holding.
  • Polymer Capital Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • Polymer Capital Management's Gilead Sciences position peaked at $521K in Q1 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.